申请人:Millennium Pharmaceuticals, Inc.
公开号:US20180009784A1
公开(公告)日:2018-01-11
This invention provides compounds of formula (I) or a pharmaceutically acceptable salt thereof, wherein T, J, R, R
4
, R
q
, o, R
A
, W and R
B
and subsets thereof are as described in the specification. The compounds are inhibitors of NAMPT and are thus useful for treating cancer, inflammatory conditions, and/or T-cell mediated autoimmune disease.